האיגוד הישראלי לרפואת משפחה

המלצות כוח המשימה הישראלי בנושא קידום בריאות ורפואה מונעת/ביבליוגרפיה למהדורת 2022

מתוך ויקירפואה


המלצות כוח המשימה הישראלי בנושא
קידום בריאות ורפואה מונעת
Ambox warning blue.png
ערך זה הוא הנחיה קלינית סגורה לעריכה
המלצות כוח המשימה.png
שם הפרק ביבליוגרפיה למהדורת 2022
עורך מדעי פרופסור אמנון להד, פרופ' חוה טבנקין, ד"ר תם אקסלרוד
מוציא לאור ההסתדרות הרפואית בישראל, האגף למדיניות רפואית, איגוד רופאי המשפחה בישראל
מועד הוצאה אוקטובר 2022
מספר עמודים 284
קישור באתר ההסתדרות הרפואית
Logo small.gif


  1. Wilson J, Junger G. The principles and practice of screening for disease. 1968.
  2. US Preventive Services Task Force. Grade Definitions After July 2012.
  3. Halperin JL, Levine GN, Al-Khatib SM, Birtcher KK, Bozkurt B, Brindis RG, et al. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System. Circulation. 2016;133)14(.
  4. משרד הבריאות. תדריך לביצוע הערכות התפתחות לתינוקות ולפעוטות עד גיל 6 שנים. 12/2016
  5. United States Preventive Services Task Force. Guide to clinical Preventive Service. 2nd ed. Baltimore, MD: Williams & Wilkins ; 1996.
  6. Canadian Task Force on the Periodic Health Examination. The Canadian Guide to Clinical Preventive Health care. Canada Communication group publishing ; 1998.
  7. Braveman P, Tarimo E. Screening in Primary Health Care:Setting Priorities With Limited Resources. WHO Publication ; 1994.
  8. משרד הבריאות. שינויים בשגרת החיסונים, 2003
  9. משרד הבריאות. הנחיות משרד הבריאות בנושא מעקב גדילה והתפתחות ילדים עד גיל 5 +עדכונים,
  10. ארגון רופאי הילדים. המלצות הוועדה המייעצת לארגון רופאי הילדים, 1992
  11. Valman HB. ABC of one to seven. Febrile convulsions. BMJ. 1993;306)6894(.
  12. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Medical Journal of Australia. 1989;150)11(.
  13. Temte JL. 2007 Childhood and adolescent immunization schedules: Evolution or intelligent design? Vol. 75, American Family Physician. 2007.
  14. משרד הבריאות. מתן חיסון פעיל נגד אבעבועות רוח. 11/2007
  15. משרד הבריאות. עדכון תדריך החיסונים של המחלקה לאפידמיולוגיה, 2007
  16. CDC. CDC Health Information for International Travel. 2008.
  17. Gahlinger PM. Motion sickness: How to help your patients avoid travel travail. Postgraduate Medicine. 1999;106)4(.
  18. אורקין י, אמיתי י, חונוביץ מ. בריאות התינוק והפעוט מידע שימושי לצוות טיפת חלב. דיונון, 2011
  19. משרד הבריאות. בדיקות סקר ביילודים לזיהוי מוקדם של מחלת תת-תריסיות, מחלת פנילקטונוריה ומחלות אחרות. 17/2009
  20. משרד הבריאות. ביצוע בדיקות דימות החושפות ילדים וילודים לקרינה מייננת. 18/2009
  21. משרד הבריאות. תדריך למניעת אנמיה וחוסר ברזל בתינוקות ובפעוטות. 17/2012
  22. ראש שירותי בריאות הציבור. שירות בריאות לתלמיד. 16/2012
  23. Beltran-Aguilar ED, Barker LK, Canto MT, Dye BA, Gooch BF, Griffin SO, et al. Surveillance for dental caries, dental sealants, tooth retention, edentulism, and enamel fluorosis--United States, 1988-1994 and 1999-2002. MMWR Surveillance summaries : Morbidity and mortality weekly report Surveillance summaries / CDC. 2005;54)3(.
  24. Petersen PE. Global policy for improvement of oral health in the 21st century - Implications to oral health research of World Health Assembly 2007, World Health Organization. Vol. 37, Community Dentistry and Oral Epidemiology. 2009.
  25. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 01/2020
  26. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 16/2014
  27. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית, חלק א: טרום לידה עד גיל 6, 08/2019
  28. קידום, הגנה ותמיכה בהנקה בטיפות חלב - חוזר משרד הבריאות - Promoting breastfeeding in family health centers
  29. Perkin MR, Logan K, Tseng A, Raji B, Ayis S, Peacock J, et al. Randomized Trial of Introduction of Allergenic Foods in Breast-Fed Infants. New England Journal of Medicine. 2016 May 5;374)18(.
  30. Meek JY, Noble L. Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics. 2022 Jul 1;150)1(.
  31. ההמלצות התזונתיות החדשות - משרד הבריאות
  32. מדריך לאנשי מקצוע להזנת התינוק והפעוט - חוזר משרד הבריאות - Infant and toddler feeding guide for healthcare professionals
  33. שינה בטוחה לתינוקות
  34. משרד הבריאות. הנחיות לשימוש בתכשירי פלואוריד. הנחיות בריאות השן מס' 3.2, 2021
  35. המחלות הנבדקות בבדיקות סקר ביילודים
  36. איתור אי יציבות מפרק הירך ביילודים ובתינוקות - חוזר משרד הבריאות - Screening for hip instability in neonates and infants
  37. עמותת גושן. פורטל בריאות ורווחת הילד בקהילה
  38. נוהל לאיתור נשים בסיכון לדיכאון בהיריון ולאחר לידה - חוזר משרד הבריאות
  39. Fixler DE, Laird WP. Validity of mass blood pressure screening in children. Pediatrics. 1983;72)4(.
  40. Zadik Z, Sthoeger D, Blachar Y. Blood pressure determinations in Israeli schoolchildren aged 5 to 14 years. Israel Journal of Medical Sciences. 1987;23)7(.
  41. Morais T, Bernier M, Turcotte F. Age- and sex-specific prevalence of scoliosis and the value of school screening programs. American Journal of Public Health. 1985;75)12(.
  42. US Preventive Services Task Force. Screening for Adolescent Idiopathic Scoliosis. JAMA. 1993;319)2(:165-72.
  43. Willers U, Svensson O, Hedlund R, Normelli H, Aaro S. Long-term results of boston brace treatment on vertebral rotation in idiopathic scoliosis. Spine )Phila Pa 1976(. 1993;18)4(.
  44. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: Results of a multicenter clinical trial of 6,630 men. Journal of Urology. 1994;151)5(.
  45. מניעה וטיפול בהשמנה משרד הבריאות
  46. עידוד פעילות גופנית משרד הבריאות
  47. טיפול בילד הבריא מטרום לידה ועד גיל 6 - הנחיה קלינית 01/2020
  48. Palti H. Blood pressure assessment in children. Isr J Med Sci. 1987;23)7(.
  49. Horan MJ, Falkner B, Kimm SYS. Report of the second task force on blood pressure control in children - 1987 - Task Force on Blood Pressure Control in Children. Pediatrics. 1987;79)1(.
  50. Baron AE, Freyer B, Fixler DE. Longitudinal blood pressures in blacks, whites, and mexican Americans during adolescence and early adulthood. American Journal of Epidemiology. 1986;123)5(.
  51. Weinstein SL, Dolan LA, Spratt KF, Peterson KK, Spoonamore MJ, Ponseti I v. Health and Function of Patients with Untreated Idiopathic Scoliosis: A 50-Year Natural History Study. J Am Med Assoc. 2003;289)5(.
  52. Berg AO. Screening for depression: Recommendations and rationale. Vol. 66, American Family Physician. 2002.
  53. Froom J, Schlager DS, Steneker S, Jaffe A. Detection of major depressive disorder in primary care patients. The Journal of the American Board of Family Practice / American Board of Family Practice. 1993;6)1(.
  54. פעילות גופנית וספורט בילדים ובבני נוער - נייר עמדה 2019
  55. US Preventive Services Task Force. Guide to Clinical Preventive Services. 3rd ed. Vol. 1. Rockville, MD: Agency for Healthcare Research and Quality (US); 2002.
  56. קנישקווי ב, אמיתי י, חונוביץ מ. בריאות התלמיד: מידע שימושי. ירושלים: משרד הבריאות 2003
  57. Berg AO. Screening for skin cancer: Recommendations and rationale. Vol. 65, American Family Physician. 2002.
  58. Lamberg L. "Epidemic“ of malignant melanoma: True increase or better detection? Vol. 287, Journal of the American Medical Association. 2002.
  59. Soldatos CR, Allaert FA, Ohta T, Dikeos DG. How do individuals sleep around the world? Results from a single-day survey in ten countries. Sleep Medicine. 2005;6)1(.
  60. Irwin MR, Wang M, Campomayor CO, Collado-Hidalgo A, Cole S. Sleep deprivation and activation of morning levels of cellular and genomic markers of inflammation. Archives of Internal Medicine. 2006;166)16(.
  61. Kahn-Greene ET, Killgore DB, Kamimori GH, Balkin TJ, Killgore WDS. The effects of sleep deprivation on symptoms of psychopathology in healthy adults. Sleep Medicine. 2007;8)3(.
  62. Alvarez GG, Ayas NT. The impact of daily sleep duration on health: a review of the literature. Vol. 19, Progress in cardiovascular nursing. 2004.
  63. Rains JC, Poceta JS. Headache and sleep disorders: Review and clinical implications for headache management. Vol. 46, Headache. 2006.
  64. Wolkove N, Elkholy O, Baltzan M, Palayew M. Sleep and aging: 1. Sleep disorders commonly found in older people. Vol. 176, CMAJ. 2007.
  65. Morin AK, Jarvis CI, Lynch AM. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Vol. 27, Pharmacotherapy. 2007.
  66. McGuire S. Institute of medicine. 2010. Strategies to reduce sodium intake in the united states. Washington, dc: The national academies press. Vol. 1, Advances in Nutrition. 2010.
  67. Sacks FM, Campos H. Dietary Therapy in Hypertension. New England Journal of Medicine. 2010;362)22(.
  68. Gidding SS, Lichtenstein AH, Faith MS, Karpyn A, Mennella JA, Popkin B, et al. Implementing american

heart association pediatric and adult nutrition guidelines. Vol. 119, Circulation. 2009.

  1. Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368)9548(.
  2. WCRF. Food, nutrition, physical activity and the prevention of cancer. The American Institute for Cancer Research )AICR(; World Cancer Research Fund )WCRF UK( World Cancer Research Fund International. 2007.
  3. Morrow JW, Keels MA, Hale KJ, Thomas HF, Davis MJ, Czerepak CS, et al. Preventive oral health intervention for pediatricians. Vol. 122, Pediatrics. 2008.
  4. Prentice A. Diet, nutrition and the prevention of osteoporosis. Public Health Nutrition. 2004;7)1a(.
  5. Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, et al. Weight Loss with a Low-

Carbohydrate, Mediterranean, or Low-Fat Diet. New England Journal of Medicine. 2008;359)3(.

  1. Widenhorn-Muller K, Hille K, Klenk J, Weiland U. Influence of having breakfast on cognitive performance and mood in 13-to 20-year-old high school students: Results of a crossover trial. Pediatrics. 2008;122)2(.
  2. US Department of Health and Human Services. 2008 Physical Activity Guidelines for Americans. Washington DC; 2008.
  3. Meriwether RA, Lee JA, Lafleur AS, Wiseman P. Physical activity counseling. Vol. 77, American Family Physician. 2008.
  4. Marcus. Erratum: Physical activity intervention studies: What we know and what we need to know: A scientific statement from the American Heart Association Council on nutrition, physical activity, and metabolism )subcommittee on physical activity(; Council on cardiovascular disease in the young. Vol. 122, Circulation. 2010.
  5. Marwick TH, Hordern MD, Miller T, Chyun DA, Bertoni AG, Blumenthal RS, et al. Exercise training for type 2 diabetes mellitus: Impact on cardiovascular risk: A scientific statement from the american heart association. Circulation. 2009;119)25(.
  6. Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MSV. Physical activity and risk of ischemic stroke in the Northern Manhattan study. Neurology. 2009;73)21(.
  7. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. The Lancet. 2009;374)9702(.
  8. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Vol. 41, Medicine and Science in Sports and Exercise. 2009.



.זלר ל, סוקניק ש. הקשר שבין עיסוק בספורט לבין התפתחות אוסטאוארתריטיס של הברכיים. הרפואה .82 2008;147)4(:315-9. 83. Lautenschlager NT, Cox KL, Flicker L, Foster JK, van Bockxmeer FM, Xiao J, et al. Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: A randomized trial. JAMA - Journal of the American Medical Association. 2008;300)9(. 84. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, Rubin RR, et al. Exercise and Type 2 Diabetes: The American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010 Dec 1;33)12(. 85. Hornsby W, Albright A. Diabetes. In: Durstine J, Moore G, editors. ACSM's Exercise Management for Persons with Chronic Diseases and Disabilities. 3rd ed. Williams & Wilkins; 2009. p. 182-91. 86. Elsawy B, Higgins KE. Physical activity guidelines for older adults. American Family Physician. 2010;81)1(. 87. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Medicine and Science in Sports and Exercise. 2011;43)7(. 88. Lee DC, Sui X, Artero EG, Lee IM, Church TS, McAuley PA, et al. Long-term effects of changes in cardiorespiratory fitness and body mass index on all-cause and cardiovascular disease mortality in men the Aerobics Center Longitudinal Study. Circulation. 2011;124)23(. 89. Haug C. The risks and benefits of HPV vaccination. Vol. 302, JAMA - Journal of the American Medical Association. 2009. 90. Rothman SM, Rothman DJ. Marketing HPV vaccine: Implications for adolescent health and medical professionalism. Vol. 302, JAMA - Journal of the American Medical Association. 2009. 91. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA - Journal of the American Medical Association. 2009;302)7(. 221 92. Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsague X, et al. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology. 2012;13)1(. 93. Wheeler CM, Castellsague X, Garland SM, Szarewski A, Paavonen J, Naud P, et al. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non¬vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. The Lancet Oncology. 2012;13)1(. 94. Palefsky JM, Giuliano AR, Goldstone S, Moreira ED, Aranda C, Jessen H, et al. HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia. New England Journal of Medicine. 2011;365)17(. 95. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, et al. Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males. New England Journal of Medicine. 2011;364)5(. 96. Read TRH, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus )HPV( vaccination programme. Sexually Transmitted Infections. 2011;87)7(. 97. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. The Lancet. 2011;377)9783(. 98. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults. New England Journal of Medicine. 2005 Jun 2;352)22(. 99. Chen N, Li Q, Zhang Y, Zhou M, Zhou D, He L. Vaccination for preventing postherpetic neuralgia. Cochrane Database of Systematic Reviews. 2011; 100. USPSTF A-Z Topic Guide. 101. Israel Center for Disease Control and MOH Department of Health Promotion and Education. INHIS and KAP surveys. 2003. איגוד רופאי הילדים. הנחיות והמלצות בנושא: רפואת מתבגרים. המפגש הרפואי עם בני נוער. ההסתדרות הרפואית .102 .2000 ;בישראל 103. הציבור רשב. טיפול בחומצה פולית להפחתת הסיכון למומים מולדים בתעלה העצבית ]Internet[. 1/2018. 2018. Available from: https://www.health.gov.il/hozer/bz01 2018.pdf 104. Sox HJ. Preventive Health Services in Adults. New England Journal of Medicine. 1994;330)22(. 105. Implementing preventive services. Based on papers prepared for the International Symposium on Preventive Services in Primary Care: Issues and Strategies. L'Esterel, Quebec, Canada, October 4-7, 1987. Am J Prev Med. 1988;4)4 Suppl(. 106. Braveman P, Tarimo E. Screening in primary health care: setting priorities with limited resources. 1994. 107. Dobrossy L. Prevention in primary care: recommendations for promoting good practice. 1994. 108. Patterson C, Chambers LW. Preventive health care. The Lancet. 1995 Jun;345)8965(. .1995 .משרד הבריאות. הנחיות משרד הבריאות בנושא מעקב נשים בהיריון+עדכונים .109 110. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of Prenatal Ultrasound Screening on Perinatal Outcome. New England Journal of Medicine. 1993;329)12(. 111. Berkowitz RL. Should Every Pregnant Woman Undergo Ultrasonography? New England Journal of Medicine. 1993;329)12(. 112. Bernaschek G, Stuempflen I, Deutinger J. The value of sonographic diagnosis of fetal malformations: Different results between indication-based and screening-based investigations. Prenatal Diagnosis. 1994;14)9(. 113. Bragonier JR, Bemis-Heys RL. Cost-effectiveness in the provision of primary health care services for women. Primary Care Update for Ob/Gyns. 1994;1)6(. 114. Roccella EJ. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure )JNC V(. Archives of Internal Medicine. 1993;153)2(. 115. Pyorala K, Backer G de, Graham I, Poole-wilson P, Wood D. Prevention of coronary heart disease in clinical practice: Recommendations of the task force of the european society of cardiology, european atherosclerosis society and european society of hypertension. European Heart Journal. 1994;15)10(. 116. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society consensus conference: 1. Introduction. Vol. 149, CMAJ. 1993. 117. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, et al. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia. New England Journal of Medicine. 1995;333)20(. 118. Summary of the Second Report of the National Cholesterol Education Program )NCEP( Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults )Adult Treatment Panel II(. JAMA: The Journal of the American Medical Association. 1993;269)23(. 119. Willett WC. Diet and health: What should we eat? Science )1979(. 1994;264)5158(. 120. Heaney RP. Optimal Calcium Intake. Vol. 274, JAMA: The Journal of the American Medical Association. 1995. 121. Rich-Edwards JW, Manson JE, Hennekens CH, Buring JE. The Primary Prevention of Coronary Heart Disease in Women. New England Journal of Medicine. 1995 Jun 29;332)26(. 122. Austoker J, Sanders D, Fowler G. Cancer Prevention in Primary Care: Smoking and cancer: Smoking cessation. BMJ. 1994;308)6942(. 123. Austoker J. Melanoma: Prevention and early diagnosis. Vol. 308, British Medical Journal. 1994. 124. Menczer J. The case against cytological mass screening for cervical cancer in Israel. Vol. 122, Harefuah. 1992. 125. Blum A, Solberg E. The role of the family physician in ending the tobacco pandemic. Vol. 34, Journal of Family Practice. 1992. 126. Kottke TE, Solberg LI, Brekke ML, Conn SA, Maxwell P, Brekke MJ. A controlled trial to integrate smoking cessation advice into primary care practice: Doctors helping smokers, round III. Journal of Family Practice. 1992;34)6(. 127. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee )ACIP(. MMWR Recommendations and reports : Morbidity and mortality weekly report Recommendations and reports / Centers for Disease Control. 1991;40)RR-13(. 128. Expanded Programme on Immunization : programme report for the year 1992, incorporating the recommendations of the Global Advisory Group, October 1992. 1993. 129. Blaine Hollinger F. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. The American Journal of Medicine. 1989;87)3 SUPPL. 1(. 130. Hall AJ. Hepatitis B vaccination: Protection for how long and against what? Vol. 307, British Medical Journal. 1993. 223 131. Bar-Shany S, Avitzur M, Tur-Kaspa R. Antibodies to hepatitis C in Israeli blood donors: age, sex and ethnic differences from HBsAg positive carriers. In: First Joint Spanish-Israeli Meeting on Liver and Biliary Disease. Jerusalem; 1992. 132. Green MS, Block C, Slater PE. Rise in the incidence of viral hepatitis in israel despite improved socioeconomic conditions. Reviews of Infectious Diseases. 1989;11)3(. 133. Bogomolski-Yahalom V, Granot E, Linder N, Adler R, Korman S, Manny N, et al. Prevalence of HBsAg carriers in native and immigrant pregnant female populations in Israel and passive/active vaccination against HBV of newborns at risk. Journal of Medical Virology. 1991;34)4(. 134. Peckham CS. Issues underlying the evaluation of screening programmes. Vol. 54, British Medical Bulletin. 1998. 135. Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine. 1992;10)SUPPL. 1(. 136. Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection Against Hepatitis A by an Inactivated Vaccine. JAMA: The Journal of the American Medical Association. 1994;271)17(. 137. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatric Infectious Disease Journal. 1993;12)5(. 138. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A Controlled Trial of a Formalin- Inactivated Hepatitis A Vaccine in Healthy Children. New England Journal of Medicine. 1992;327)7(. 139. Bancroft WH. Hepatitis A Vaccine. New England Journal of Medicine. 1992 Aug 13;327)7(. 140. Tormans G, van Damme P, van Doorslaer E. Cost-effectiveness analysis of hepatitis A prevention in travellers. Vaccine. 1992;10)SUPPL. 1(. 141. van Damme P, Cramm M, van der Auwera JC, Meheus A. Hepatitis A vaccination for health care workers. BMJ. 1993 Jun 12;306)6892(. 142. Tilzey AJ, Palmer SJ, Barrow S, Perry KR, Tyrrell H, Safary A, et al. Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. British Medical Journal. 1992;304)6837(. 143. Behrens RH, Roberts JA. Is travel prophylaxis worth while? Economic appraisal of prophylactic measures against malaria, hepatitis A, and typhoid in travellers. BMJ. 1994;309)6959(. 144. Green MS, Cohen D, Lerman Y, Sjogren M, Binn LN, Slepon R, et al. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine. In: Israel Journal of Medical Sciences. 1994. 145. Karetnyi Y v., Mendelson E, Shlyakhov E, Rubinstein E, Golubev N, Levin R, et al. Prevalence of antibodies against hepatitis A virus among new immigrants in Israel. Journal of Medical Virology. 1995;46)1(. 146. Ministry of Health I. Hepatitis A in Israel - 1993. Monthly Epidemiological Record. 1993. 147. Bader TF. Hepatitis A vaccine. Am J Gastroenterol. 1996 Feb;91)2(. 148. Modan B, Shpilberg O, Anis E, Chetrit A, Luxenburg O, Rosenberg E, et al. The need for liver transplantation: a nationwide estimate based on consensus review. The Lancet. 1995;346)8976(. 149. Ackerman Z, Ablin J, Shouval D. Active immunization against hepatitis A is now warranted in glucose-6- phosphate dehydrogenase-deficient subjects ]12[. Vol. 91, American Journal of Gastroenterology. 1996. 150. Krause DS. Hepatitis A Vaccines. JAMA: The Journal of the American Medical Association. 1996 Aug 14;276)6(. 151. Adler R, Shouval D. Hepatitis a prophylaxis vaccine or immunoglobulin? Clinical Immunotherapeutics. 1996;6)4(.